Condition (MeSH)
Dysuria
ClinicalTrials.gov lists 20 trials for Dysuria or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
20 of the 20 trials are tagged with Dysuria itself; the rest are tagged with a narrower condition beneath it.
When did Dysuria trials start? (13)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 2
- Phase 3
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2022 | 3 |
| 2021 | 1 |
| 2020 | 1 |
| 2018 | 3 |
| 2017 | 3 |
| 2016 | 2 |
| 2015 | 1 |
| 2014 | 1 |
| 2012 | 1 |
Showing 10 of 13 earlier years.
No forecast is made for this condition: it averages 1.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Dysuria trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 3 | 5 |
| Not applicable | 8 |
| Observational | 5 |
How many Dysuria trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 2 |
| Completed | 10 |
| Terminated | 4 |
| Unknown status | 4 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Dysuria trials? (8)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Assaf-Harofeh Medical Center | 1 |
| EMS | 1 |
| Laboratorios Osorio de Moraes Ltda. | 1 |
| Medical Diagnostic Laboratories, LLC | 1 |
| Mylan Pharmaceuticals Inc | 1 |
Showing 5 of 8 sponsors.
Which drugs are being tested for Dysuria? (3)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Phenazopyridine | 2 |
| Estradiol | 1 |
| Tamsulosin | 1 |
Interventions as named in the registry (9)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| PP4001 | 1 |
| Pílulas de Lussen | 1 |
| Methenamine and Methylthioninium chloride | 1 |
| Vehicle Cream | 1 |
| Lidocaine Jet Injector | 1 |
Showing 5 of 9 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Dysuria trials report? (5)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Cardiac Arrest | 1 | 1 |
| Cardiac Tamponade | 1 | 1 |
| Exacerbation of Chronic Obstructive Pulmonary Disease | 1 | 1 |
| Pericardial Haemorrhage | 1 | 1 |
| Sick Sinus Syndrome | 1 | 1 |
Which publications cover Dysuria? (25)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Clinical profile of comorbid dysmenorrhea and bladder sensitivity: a cross-sectional analysis. | American journal of obstetrics and gynecology | 2020 | Yes |
| The most bothersome symptom of vaginal atrophy: Evidence from the observational AGATA study. | Maturitas | 2018 | Yes |
| Low-Power Vs High-Power Holmium Laser Enucleation of the Prostate: Critical Assessment through Randomized Trial. | Urology | 2018 | Yes |
| Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. | Maturitas | 2014 | Yes |
| Efficacy of butylscopolamine for the treatment of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study. | British journal of anaesthesia | 2013 | Yes |
Showing 5 of 25 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.